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1. Introduction
  Clausena anisata (Wild) Hook .F. ex Benth (Rutaceae) 
(syn. Clausena abyssinica (Engl.) Engl., Clausena  inequalis 
(DC.) Benth.) (C. Anisata) is a tropical shrub or tree up 
to 10 meters high growing in and on evergreen forests. It 
is commonly known as ‘mbiet ekpene’ by the Ibibios of 
Niger Delta region of Nigeria. The plant is traditionally 
used as effective remedies for worms infections, respiratory 
ailments, hypertension, malaria, fever, rheumatism, 
arthritis and other inflammatory conditions, headaches, 
pains, toothaches, convulsions and others[1]. The Ibibios 
use the plant to treat measles, malaria, pains and 
inflammations[2]. The plant has been reported to contain 
coumarins, limonoids, carbazole alkaloids, monoterpenoids 
furanocoumarin lactones and essential oils[3,4]. Reports of 
antibacterial[1], antidiabetic[5], antitumor promoting[4], and 
in vitro antimalarial[6]  activities have been published. This 
study was carried out to evaluate the in vivo antiplasmodial 
and analgesic activities of this plant to correlate the 
reported in vitro antiplasmodial activity and confirm its 
traditional use for malaria and pains.
2. Materials and methods
2.1. Plant materials 
  The fresh leaves of Clausena anisata (Wild) Hook .F. 
ex Benth (Rutaceae) (C. anisata) were collected from the 
Ukap in Ikono area of Akwa Ibom State and were identified 
and authenticated by Dr. (Mrs.) Margaret Bassey of the 
Department of Botany and Ecological studies, University of 
Uyo and  deposited at University of Uyo  herbarium (UUH 
653). 
Objective: Antiplasmodial and analgesic activities of the leaf extract and fractions of Clausena 
anisata (C. anisata) were evaluated for antimalarial and analgesic activities. Methods: The 
crude leaf extract (39 - 117 mg/kg) and fractions (chloroform and acqeous; 78 mg/kg) of C. 
anisata  were investigated for antiplasmodial activity against chloroquine-sensitive Plasmodium 
berghei  (P. berghei ) infections in mice using suppressive, prophylactic and curative models and 
analgesic activity against acetic acid, formalin and heat-induced pains. Artesunate, 5 mg/kg and 
pyrimethamine, 1.2 mg/kg were used as positive controls. Thin films made from tail blood of each 
mouse were used to assess the level of parasitaemia of the mice. Results: The extract and its 
fractions dose-dependently reduced parasitaemia induced by chloroquine-sensitive  P. berghei 
in prophylactic, suppressive and curative models in mice. These reductions were statistically 
significant (P<0.001). They also improved the mean survival time (MST) from 17 to 21 days 
relative to control (P<0.01 - 0.001).  On chemically and thermally- induced pains, the extract 
inhibited acetic acid and formalin-induced inflammation as well as hot plate-induced pain in 
mice. These inhibitions were statistically significant (P<0.001) and in a dose-dependent fashion. 
Conclusions:  The antiplasmodial and analgesic effects of this plant may in part be mediated 
through its chemical constituents and  it can be concluded that the C. anisata possess significant 
antimalarial and analgesic properties.  
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2.2. Extraction
  The leaves of the plant were air-dried, pulverized using 
a pestle and mortar and cold-macerated for 72 hours using 
ethanol. The liquid ethanolic extract that was obtained by 
filtration was evaporated to dryness in a waterbath at 60 曟
and was partitioned with a 50:50 mixture of distilled water 
and chloroform. The acqueous fraction was evaporated 
to dryness in a water bath at 60 曟 and the chloroform 
fraction air-dried. The ethanolic extract, the acqueous and 
chloroform fractions were stored at -4 曟 until use.
2.3. Phytochemical screening
  Phytochemical screening of the crude leaf extract was 
carried out employing standard procedures and tests[7], 
to reveal the presence of chemical constituents such 
as alkaloids, flavonoids, tannins, terpenes, saponins, 
anthraquinones, reducing sugars, cardiac glycosides among 
others.
2.4. Animals
  Both male and female animals (Swiss albino mice) used 
for these experiments were obtained from University of Uyo 
animal house. The animals were housed in standard cages 
and were maintained on a standard pelleted Feed (Guinea 
Feed) and water ad libitum. Permission and approval 
for animal studies were obtained from College of Health 
Sciences Animal Ethics committee, University of Uyo. 
2.5. Microorganism
  A chloroquine sensitive strain of Plasnodium berghei (P. 
berghei) was obtained from the National Institute of Medical 
Research (NIMER), Lagos and was maintained by subpassage 
in mice.
2.6. Determination of median lethal dose (LD50)                     
  The median lethal dose (LD50) of the extract was estimated 
using albino mice by intraperitoneal (i.p) route using the 
method of Miller and Tainter[8]. This involved intraperitoneal 
administration of different doses of the extract (100 - 1 000 mg/kg)
to groups of three mice each. The animals were observed for 
manifestation of physical signs of toxicity such as writhing, 
decreased motor activity, decreased body/limb tone, 
decreased respiration and death. 
2.7. Evaluation of antiplasmodial activity of the extract/
fractions
  The evaluation of suppressive activity (4-day test) of the 
extract, fractions and artesunate against early P. berghei 
infection in mice was done with modifications as earlier 
described[9,10]. On the first day (DO), the forty-two mice 
were infected with the parasite and randomly divided into 
7 groups of six mice each. The mice in groups 1- 3 were 
administered with the 39, 78, and 117 mg/kg of crude extract, 
groups 4 - 5 were administered with the 78 mg/kg of the 
chloroform and aqueous fractions respectively, while group 
6 was administered with 5 mg/kg of artesunate (positive 
control), and 10 mL/kg of distilled water to group 7 (negative 
control) for four consecutive days (D0 - D3) between 8 am and 
9 am. On the fifth day (D4), thin blood film was made from 
tail blood. The film was then stained with leishman stain to 
reveal parasitized erythocytes out of 500 in a random field 
of the microscope. The average percentage suppression of 
parasitaemia was calculated in comparison with the controls 
as follows:
Average % parasitaemia in 
negative control
Average % parasitaemia in 
positive groups-
Average % parasitaemia in negative control
  The evaluation of curative activities of extract and 
fractions of C. anisata in established infection were done 
with modifications as earlier described[9,10]. P. berghei was 
injected intraperitoneally into another 42 mice on the first 
day (DO). Seventy-two hours later (D3), the mice was divided 
randomly into seven groups of six mice each and treated 
as above with extract, fractions and artesunate once daily 
for 5 days. Leishman’s stained thin smears were prepared 
from tail blood samples collected on each day of treatment 
to monitor parasitaemia level. The mean survival time (MST) 
of the mice in each treatment group was determined over a 
period of 29 days (D0 - D28).
  
No of days survived 
Total No. of days (29)
伊100 = MST  
  Prophylactic or repository activities of extract and fractions 
were assessed by using the method earlier described[9,11]. 
The mice were treated as above  for three days but 1.2 mg/kg/day 
of pyrimethamine was given to group 6 (positive control). On 
the fourth day (D3) the mice were inoculated with P. berghei. 
The parasitaemia level was assessed by blood smears 
seventy-two hours later.  
2.8. Evaluation of analgesic potential of the extract 
  Acetic acid induced writhing in mice was carried out 
according to the procedure  earlier described[12-14] The 
animals were divided into 5 groups of 6 mice per group. 
Group 1 served as negative control and received 10 mL/kg
of normal saline, while groups 2, 3 and 4 were pre-
treated with 39, 78 and 117 mg/kg doses of C. anisata 
extract intraperitoneally and group 5 received 100 mg/kg
of acetyl salicylic acid. After 30 minutes, 0.2 mL of 2% 
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acetic acid was administered intraperitoneally (i.p). The 
number of writhing movements was counted for 30 minutes. 
Antinociception (analgesia) was expressed as the reduction 
of the number of abdominal constrictions between control 
animals and mice pretreated with extracts.
  Formalin - induced hind paw licking in mice was carried 
out according to a modified method earlier described[14-16] 
The animals were  treated as above but injected with 20 毺L
of 2.5% formalin solution (0.9% formaldehyde) made up in 
phosphate buffer solution (PBS concentration: Nacl 137 mM, 
Kcl 2.7 mM and phosphate buffer, 10 mM) subcutaneously 
under the surface of the right hind paw 30 minutes post-
treatment. The amount of time spent licking the injected paw 
was timed and considered as indication of pain. The first 
phase of the nociceptive response normally peaks 5 minutes 
after injection and the second phase 15 - 30 minutes 
after formalin injection, representing the neurogenic and 
inflammatory pain responses, respectively[15]. The responses 
were measured for 5 mins (first phase)  and 15 - 30 mins 
after formalin injection (second phase), respectively. 
  For hot-plate test, the hot plate was maintained at (45依1) 曟.
Each animal was placed into a glass beaker of 50 cm 
diameter on the heated surface 30 minutes post-treatment 
with extract/fractions and standard drug as above. The 
time(s) between placement and shaking or licking of the 
paws or jumping was recorded as the index of response 
latency. An automatic 30-second cut-off was used to 
prevent tissue damage[12,13,17]. 
2.9. Statistical analysis 
  Data obtained from this work were analyzed statistically 
using  Students’ t-test and ANOVA (One- way) followed 
by a  post test (Tukey-Kramer multiple comparison test). 
Differences between means will be considered significant at 
1% and  5% level of significance i.e P ≤ 0.01and 0.05.
3. Results
3.1. Phytochemical screening
  The phytochemical screening of the ethanolic extract of 
the leaves of C. anisata revealed the presence of cardiac 
glycosides, tannins, saponins, terpenes and flavonoids.
3.2. Acute toxicty
  The median lethal dose (LD50) was calculated to be (393.70 
依 25.64) mg/kg. The physical signs of toxicity included 
excitation, paw licking, increased respiratory rate, decreased 
motor activity, gasping and coma which was followed by 
death.
3.3. Effect on suppressive activity of ethanolic leaves extract 
and fractions of C. anisata
  The extract and its fractions showed a dose-dependent 
chemosuppressive effect on the parasitaemia. These effects 
were statistically significant relative to the control (P<0.001). 
The chemoinhibitory percentages ranged from 52.51 to 82.02 
(Table 1). The acqueous fraction had a higher antiplasmodial 
potential which was more than that of the standard drug, 
artesunate. 
3.4. Effect on repository activity of ethanolic leaves extract 
and fractions  of C. anisata
  The ethanolic leaf extract showed a dose-dependent 
chemosuppressive effect on the parasitaemia. This effect 
was statistically significant relative to the control (P<0.001). 
Similarly the acqeous fraction exerted a higher activity that 
was significant relative to the control but less than that of 
the standard drug, pyrimethamine (Table 2).
 
3.5. Antiplasmodial effect of ethanolic leaf extract and 
fractions of C. anisata on established infection
  On established infection, it was observed that there was 
a daily increase in parasitaemia of the control group. 
However, there was a daily reduction in the parasitaemia 
levels of the extract/fractions- treated groups as well as that 
of positive control (artesunate).  
  The extract and its fractions showed a dose- dependent 
schizonticidal effect on the parasitaemia. These effects 
were statistically significant relative to the control (P<0.001)
(Figure 1). Though both the extract and  its fractions 
showed a significant  dose -dependent  mean survival 
time on established infection (P<0.001), the standard drug, 
artesuante showed greater protective effect with a much 
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Figure 1.  Curative  effect of ethanolic leaves extract and fractions of 
C. anisata on P. berghei  established infection in mice.
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Figure 2. Mean survival time (MST) of mice receiving various doses of 
ethanolic leaves extract and fractions of C. anisata during established 
infection. 
3.6. Effect of ethanolic crude extract of leaves of C. anisata 
on acetic acid-induced writhing in mice
  The extract (39-117 mg/kg) demonstrated a dose-
dependent reduction in acetic acid-induced writhing in 
mice. The reductions were statistically significant (P<0.001) 
relative to control and comparable to that of the standard 
drug, ASA, at the highest dose, 117 mg/kg. (Table 3).
3.7. Effect of ethanolic leaves extract of C. anisata on 
formalin-induced hind paw licking in mice
  The extract exhibited a dose- dependent effect on 
formalin-induced hind paw licking in mice. This inhibition 
was significant relative to the control (P<0.001) and 
comparable to that of the standard drug, ASA, at the highest 
dose, 117 mg/kg. (Table 4).
3.8. Effect of ethanolic crude extract of leaves of C. anisata 
on thermally-induced pain in mice
  The extract exhibited a dose - dependent effect on 
thermally-induced  pain in mice. This inhibition was 
statistically significant relative to the control (P<0.001) 
(Table  5). 
Table 1
Suppressive activity of ethanolic leaves extract and fractions of C. anisata  on P. berghei infection in mice(4-day test).
Treatments Dose(mg/kg) Parasitaemia % Chemosuppression
Normal saline 10 mL/kg 46.33 0.33 -
C. anisata Crude extract 39 22.0 4.93a 52.51
78 15.66  1.85a 66.13
117 16.66  2.72a 64.04
Acqueous fraction 78 8.33  2.37a 82.02
Chloroform fraction 78 19.02 2.08a 58.94
Artesunate   5.0 9.0  3.00a 80.57
 Values are expressed as mean 依 SEM. Significance relative to control aP<0.001,   n = 6.
Table 2
Repository/Prophylactic activity of ethanolic leaves extract and fractions of C.  anisata  on P. berghei infection in mice.
Treatments Dose Parasitaemia % Chemosuppression
Distilled water 10 mL/kg 32.00依5.56 -
C. anisata  crude extract 39 mg/kg 19.00依2.08a 40.62
78 mg/kg 12.00依2.51a 62.50
117 mg/kg   7.66依1.76a 24.34
Aqueous fraction 78 mg/kg   9.66依3.18a 69.81
Chloroform fraction  78 mg/kg 12.33依3.18a 61.46
Pyrimethamine 1.2 mg/kg   8.00依0.42a  75.00
Values are expressed as mean 依 SEM. Significance relative to control aP<0.001, n= 6. 
 
Table 3
Effect of ethanolic leaves extract  of  Clausena anisata on acetic acid induced writhing in mice.
TREATMENT Dose(mg/kg)
Time interval (MINS)
5 10 15 20 25 30 
Normal saline   10 5.67依0.87 9.11依 0.67 12.31依0.04 16.32依0.50 15.14依0.11 14.0依0.21
C. anisata   39  1.00依0.11a 6.10依0.26a     8.11依0.21a     7.45依0.30a     5.37依0.65a   4.14依0.66a
  78  0.00依0.00a 5.22依0.32a     7.54依0.42a     5.16依0.38a     4.88依0.42a   3.65依0.35a
117  0.00依0.00a 3.64依0.18a     4.76依0.20a     3.88依0.72a     3.45依0.14a        3.11依0.25a
ASA  0.43依0.12a 1.34依0.11a     1.40依0.20a     3.95依0.86a     3.67依0.22a   3.48依0.43a
Values are expressed as mean 依 SEM. Significance relative to control, aP<0.001,  n=6.
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4. Discussion 
  C. anisata have been in use traditionally in the treatment 
of different ailments ranging from malaria, convulsion, 
inflammation, worm infection to pains[1]. The Ibibios of 
Niger Delta region of Nigeria have been using it to treat 
malaria, hemorroids, pains and other febrille illnesses. 
These prompted the need to evaluate the antiplasmodial 
and analgesic potentials of the crude extract, acqueous and 
chloroform fractions of the leaves of C. anisata.
  In this work, median lethal dose (LD50) was determined  to 
be (393.70 依 25.64) mg/kg and the extract was relatively safe.
The antiplasmodial properties of the extract and its fractions 
were investigated using standard models. The extract and 
its fractions exerted significant reduction of parasitaemia 
in prophylactic, suppressive and curative models in a dose 
- dependent fashion. These activities could be attributed 
to some secondary metabolites of this plants which have 
been reported to have antiplasmodial activity with varying 
mechanisms of action. Among these metabolites are 
alkaloids, flavonoids and triterpenoids such as limonoids 
and quassinoids[18]. These compounds (alkaloids, flavonoids, 
monoterpenes  and triterpenoids) present in this plant 
extract may in part have contributed to the plasmocidal 
activity of this extract and therefore explained the 
mechanism of antiplasmodial effect of the extract and its 
fractions.
  The extract significantly reduced acetic acid-induced 
writhing, formalin-induced hind paw licking as well as 
delayed the reaction time of animals (mice)  to thermally 
induced pain. Acetic acid causes inflammatory pain by 
inducing capillary permeability and in part through local 
peritoneal receptors  from peritoneal fluid concentration 
of PGE2 and PGF2毩[19] . This test alone can not specify 
the involvement of either central or peripheral activity[20]. 
Thus, formalin tests as well as hot-plate test is usually 
carried out in addition to the above to distinguish between 
peripheral and central pain. Centrally acting drugs inhibit 
both abdominal constriction test and hot plate tests[21], while 
the peripherally acting drugs inhibit only the abdominal 
constriction[22]. 
  Formalin exhibits neurogenic and inflammatory pains[23] 
and measures both centrally and peripherally mediated 
activities that is characteristic of  biphasic pain response. 
The injection of formalin has been reported to cause an 
immediate and intense increase in the spontaneous activity 
of C fiber afferent and evokes a distinct quantifiable 
behavior indicative of pain demonstrated in paw licking by 
the animals[24-30].
  The study also shows that the extract significantly delayed 
the reaction time of thermally-induced (hot plate) test. 
This model is selective for centrally acting analgesics and 
indicates narcotic involvement[31] with opiod receptors. 
  The antinociceptive activities exerted by this extract may 
be attributed to the presence of secondary metabolites like 
saponins, flavonoids, tannins, terpenes. Flavonoids also 
have anti-inflammatory effects through its inhibition of the 
cyclo-oxygenase pathway[32]. That the extract inhibited 
neurogenic and non-neurogenic pains as well as narcotic 
pains may in part explain the mechanisms of its action 
and these effects are due to the present of phytochemical 
components in the extract.
  The results of this study support the ethnobotanical use of 
the plant in the treatment of febrile illnesses, malaria and 
pains. Further investigation is being advocated especially 
in elucidating cellular mechanisms and establishing 
structural components of the active ingredients with a view 
of standardizing them.
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Table 4
Effect of ethanolic leaves extract of C. anisata on formalin induced paw licking in mice.
Treatment Dose (mg/kg) 0 - 5mins % Inhibition 15 - 30mins % Inhibition
Normal saline       10 18.24 依 0.64      - 25.44 依 0.35       -
C. anisata
       39   9.54 依 0.36a    47.69  12.45 依 0.21a   51.06
     78   4.82 依 0.98a    75.21   7.44 依 0.28a   70.75
   117   2.14 依 0.46a    88.26   3.54 依 0.76a   86.08
   ASA    100   2.28 依 0.22a    87.50   3.65 依 0.24a   85.65
Values are expressed as mean 依 SEM. Significance relative to control. aP <0.001, n=6 
Table 5
Effect of Clausena anisata leaf extract on hot plate test
Group DoseMg/kg Reaction time (sec)(mean 依 SEM) % inhibition
Control - 2.98 依 0.26 -
C. anisata 39 3.74 依 0.57 25.50
78 4.55 依 0.30a 52.68
117 7.48 依 0.15b 151.00
ASA 100 15.32 依 0.42b 414.09
Data are expressed as mean 依 SEM.  Significant at aP < 0.05, bP < 0.001 when compared to control. n = 6.
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